Skip to main content

Diabetes

  • Mobile app helps patients, cos. increase adherence

    Diabetics are most adherent around meal times, especially during breakfast and toward the beginning of the week, according to a review of Medisafe’s more than 160,000 diabetes patients who utilize its adherence tool in an effort to better manage the condition.

    (To view the full Diabetes Report, click here.)

  • Ascensia Diabetes Care launches global social media campaign

  • Study: CLIA waivers can empower pharmacists to fill PCP care gap

    FAIRFAX, Va. - Pharmacists and lab technicians are capable of absorbing the additional health management responsiblities currently being created by the reduction in primary care physicians, according to a new study published by the Mercatus Center at George Mason University. According to the Department of Health and Human Services, the physician shortage could reach as high as a shortage of 20,000 primary care physicians by 2020.

  • ShopRite teams up with Paramount Rx on glucose screenings

    CARY, N.C. -- ShopRite is joining forces with prescription benefits manager Paramount Rx this November for National Diabetes Awareness Month, hosting free blood glucose screenings at select ShopRite locations.

    ShopRite’s registered dietitians will assist with glucose-level tests and share expert tips with residents to help prevent and treat the disease.

  • ADA now recommends diabetics perform light activity every 30 minutes

    ALEXANDRIA, Va. - The American Diabetes Association on Tuesday released updated, comprehensive guidelines for regular, structured physical exercise for everyone with diabetes and recommends less overall sedentary time every day.

  • Safeway to open weight loss clinics in 5 Bay Area stores

    SAN FRANCISCO — Weight loss clinics will soon be coming to several Bay Area Safeway stores. Safeway, alongside Costa Mesa, Calif.-based weight loss clinic chain Lean for Life By Lindora Clinic, announced Friday that Lean for Life by Lindora Clinics will be opening on Oct. 10 at five Safeway stores in Danville, Dublin, Livermore, Menlo Park and San Jose. 
     

  • FDA approves Medtronics’ ‘artificial pancreas’ for Type 1 diabetes

    SILVER SPRING, Md. — The Food and Drug Administration this week approved a new device that can automatically monitor glucose levels and provide doses of basal insulin for patients 14 years and older with Type 1 diabetes. Medtronic’s MiniMed 670G hybrid closed loop system is often called an ‘artificial pancreas’ because of its ability to adjust insulin levels with little user input. 
     

  • FDA approves Janssen’s Invokamet XR

    SILVER SPRING, Md. — The Food and Drug Administration has approved Janssen Pharmaceuticals’ Invokamet XR, a once-daily, extended-release combination therapy of Invokana (canagliflozin) and metformin, the company announced Wednesday. The drug is indicated as a first-line treatment to improve blood glucose control in adults with Type 2 diabetes alongside diet and exercise. 
     
X
This ad will auto-close in 10 seconds